Patents by Inventor Son-Mi Park

Son-Mi Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention and treatment of thromboembolic disorders
    Patent number: 9539218
    Abstract: The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
    Type: Grant
    Filed: January 19, 2006
    Date of Patent: January 10, 2017
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Frank Misselwitz, Dagmar Kubitza, Son-Mi Park, Klaus Wehling
  • Prevention and Treatment of Thromboembolic Disorders
    Publication number: 20090004265
    Abstract: The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
    Type: Application
    Filed: January 19, 2006
    Publication date: January 1, 2009
    Applicant: BAYER HEALTHCARE AG
    Inventors: Frank Misselwitz, Dagmar Kubitza, Son-Mi Park, Klaus Wehling